Vanguard Group’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
3,706,452
+37,189
+1% +$128K ﹤0.01% 2778
2025
Q1
$10.9M Buy
3,669,263
+25,841
+0.7% +$76.5K ﹤0.01% 2802
2024
Q4
$11.1M Buy
3,643,422
+7,231
+0.2% +$22.1K ﹤0.01% 2893
2024
Q3
$9.27M Buy
3,636,191
+37,218
+1% +$94.9K ﹤0.01% 2996
2024
Q2
$11.7M Buy
3,598,973
+107,724
+3% +$351K ﹤0.01% 2823
2024
Q1
$18.5M Sell
3,491,249
-310,832
-8% -$1.65M ﹤0.01% 2644
2023
Q4
$16.5M Buy
3,802,081
+29,688
+0.8% +$129K ﹤0.01% 2683
2023
Q3
$9.92M Buy
3,772,393
+8,262
+0.2% +$21.7K ﹤0.01% 2885
2023
Q2
$13.3M Sell
3,764,131
-7,214
-0.2% -$25.5K ﹤0.01% 2790
2023
Q1
$11.7M Buy
3,771,345
+182,423
+5% +$564K ﹤0.01% 2855
2022
Q4
$15.2M Sell
3,588,922
-34,707
-1% -$147K ﹤0.01% 2759
2022
Q3
$8.59M Sell
3,623,629
-7,800
-0.2% -$18.5K ﹤0.01% 3028
2022
Q2
$10.3M Buy
3,631,429
+164,589
+5% +$469K ﹤0.01% 2974
2022
Q1
$9.99M Sell
3,466,840
-213,347
-6% -$614K ﹤0.01% 3154
2021
Q4
$11.2M Buy
3,680,187
+50,754
+1% +$154K ﹤0.01% 3146
2021
Q3
$25.4M Buy
3,629,433
+43,390
+1% +$304K ﹤0.01% 2716
2021
Q2
$32.9M Buy
3,586,043
+47,588
+1% +$437K ﹤0.01% 2582
2021
Q1
$34.4M Buy
3,538,455
+141,766
+4% +$1.38M ﹤0.01% 2511
2020
Q4
$34.9M Sell
3,396,689
-77,107
-2% -$791K ﹤0.01% 2377
2020
Q3
$35.1M Sell
3,473,796
-852,192
-20% -$8.6M ﹤0.01% 2196
2020
Q2
$45.1M Sell
4,325,988
-308,709
-7% -$3.22M ﹤0.01% 2058
2020
Q1
$39.1M Buy
4,634,697
+648,571
+16% +$5.47M ﹤0.01% 1982
2019
Q4
$34.9M Buy
3,986,126
+490,422
+14% +$4.29M ﹤0.01% 2278
2019
Q3
$37.6M Buy
3,495,704
+430,025
+14% +$4.63M ﹤0.01% 2199
2019
Q2
$39M Buy
3,065,679
+118,785
+4% +$1.51M ﹤0.01% 2230
2019
Q1
$114M Buy
2,946,894
+152,157
+5% +$5.9M ﹤0.01% 1682
2018
Q4
$56.9M Sell
2,794,737
-24,381
-0.9% -$496K ﹤0.01% 1960
2018
Q3
$129M Buy
2,819,118
+85,319
+3% +$3.91M 0.01% 1668
2018
Q2
$162M Buy
2,733,799
+84,000
+3% +$4.97M 0.01% 1493
2018
Q1
$180M Buy
2,649,799
+34,730
+1% +$2.36M 0.01% 1350
2017
Q4
$259M Buy
2,615,069
+65,841
+3% +$6.51M 0.01% 1125
2017
Q3
$305M Buy
2,549,228
+74,584
+3% +$8.93M 0.01% 990
2017
Q2
$216M Buy
2,474,644
+45,735
+2% +$4M 0.01% 1183
2017
Q1
$90.4M Buy
2,428,909
+101,722
+4% +$3.78M ﹤0.01% 1709
2016
Q4
$71.4M Buy
2,327,187
+323,201
+16% +$9.92M ﹤0.01% 1799
2016
Q3
$134M Buy
2,003,986
+74,579
+4% +$5M 0.01% 1388
2016
Q2
$57.5M Buy
1,929,407
+95,570
+5% +$2.85M ﹤0.01% 1836
2016
Q1
$53.9M Buy
1,833,837
+44,725
+2% +$1.31M ﹤0.01% 1832
2015
Q4
$140M Buy
1,789,112
+14,139
+0.8% +$1.11M 0.01% 1230
2015
Q3
$134M Buy
1,774,973
+24,932
+1% +$1.88M 0.01% 1234
2015
Q2
$204M Buy
1,750,041
+90,443
+5% +$10.6M 0.01% 1042
2015
Q1
$392M Buy
1,659,598
+136,483
+9% +$32.2M 0.03% 697
2014
Q4
$288M Buy
1,523,115
+21,899
+1% +$4.14M 0.02% 776
2014
Q3
$358M Buy
1,501,216
+9,043
+0.6% +$2.16M 0.03% 654
2014
Q2
$98.5M Buy
1,492,173
+1,479
+0.1% +$97.6K 0.01% 1408
2014
Q1
$155M Buy
1,490,694
+163,656
+12% +$17M 0.01% 1070
2013
Q4
$137M Buy
1,327,038
+99,778
+8% +$10.3M 0.01% 1111
2013
Q3
$65.9M Buy
1,227,260
+190,873
+18% +$10.2M 0.01% 1534
2013
Q2
$46M Buy
+1,036,387
New +$46M ﹤0.01% 1678